Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GEN1053 |
Trade Name | |
Synonyms | BNT 313|BNT-313|BNT313|GEN 1053|GEN-1053 |
Drug Descriptions |
GEN1053 is a hexamer-forming antibody that targets CD27, potentially leading to increased CD27-dependent signaling, expansion of immune cells, and activation of cytotoxic T-lymphocyte (CTL) mediated antitumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C189061 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GEN1053 | GEN1053 | 0 | 1 |